Phage display selection of a peptide DNase II inhibitor that enhances gene delivery

The Journal of Gene Medicine
J J SperindeFrancis C Szoka

Abstract

Nuclease activity is thought to be a significant barrier to effective gene delivery employing synthetic vectors. In particular, the lysosomal DNase, DNase II, has significant access to plasmid DNA, when the protective condensing agent has been shed. Here, we present the identification of a peptide DNase II inhibitor, enabling enhanced levels of gene delivery. A DNase II inhibitor was identified by phage display from a cyclic, random 12-amino acid library. Activity was assayed by inhibition of DNase II degradation of DNA. Transfection enhancement levels were measured over a range of DNA doses with CV-1 and MDBK cell types using PEI and cationic lipoplexes as vectors. We postulated that a DNase II inhibitor would enhance transfection by enabling a larger fraction of plasmid DNA to traffic through the cell and enter the nucleus. Peptides based on the selected sequence (SLRLLQWFLWAC) [ID2] were shown to inhibit DNase II with an observed KI,app of 0.2-2 microM. Lipoplex-mediated transfection in vitro was found to be enhanced by ID2-3 across the entire range of plasmid DNA doses examined (0.10-3.0 microg/mL). Transfection with PEI/DNA complexes was found to be specifically enhanced in the presence of ID2 peptides, with a saturable DN...Continue Reading

References

Nov 7, 1977·Biochemical and Biophysical Research Communications·S SekiT Oda
Jul 27, 1990·Science·J K Scott, G P Smith
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M ZenkeM L Birnstiel
Dec 10, 1973·Biochemical and Biophysical Research Communications·T Blumenthal, T A Landers
Jan 1, 1971·Pure and Applied Chemistry. Chimie Pure Et Appliquée·F B Straub
Oct 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·A P Grollman, M L Stewart
Jan 1, 1993·Journal of Enzyme Inhibition·K SuzukiM Uyeda
Sep 1, 1993·Bioconjugate Chemistry·J Haensler, F C Szoka
Mar 28, 1996·Nature·R Pasqualini, E Ruoslahti
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·K YoonE B Kmiec
Jun 13, 1998·The Journal of Biological Chemistry·M D BallingerJ A Wells
Jul 31, 1999·Human Gene Therapy·J Glasspool-Malone, R W Malone
Aug 3, 1999·Biological Chemistry·H Büeler
Jun 10, 2000·Analytical Biochemistry·S J Choi, F C Szoka
Apr 1, 1958·Archives of Biochemistry and Biophysics·G L ELLMAN

❮ Previous
Next ❯

Citations

Jul 12, 2002·The Journal of Gene Medicine·Jill Glasspool-MaloneRobert W Malone
Feb 6, 2002·Current Opinion in Chemical Biology·Diane J RodiBrian K Kay
Jan 12, 2012·Virology Journal·Irshad Ul HaqIshtiaq Qadri
Jan 21, 2014·Applied Microbiology and Biotechnology·Jessica NicastroRoderick A Slavcev
Apr 7, 2012·European Journal of Medicinal Chemistry·Haigang ChenXin Guo
Sep 17, 2009·The Journal of Gene Medicine·Thomas P HerringsonJoseph G Altin
Oct 31, 2016·Advanced Drug Delivery Reviews·Mahdi KarimiMichael R Hamblin
Mar 15, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kalle KilkUlo Langel
Mar 29, 2006·Trends in Biotechnology·Jason R Clark, John B March
Oct 26, 2007·Biochemical and Biophysical Research Communications·Lukas J A C HawinkelsErik A L Biessen
Sep 3, 2002·Chemistry & Biology·Lihui XuDasa Lipovsek
Oct 9, 2016·Folia Microbiologica·Sonika SharmaMohan G Vairale
Dec 11, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dasein Pinto-González HowellMichael A Barry
Jan 23, 2019·Angewandte Chemie·Ved PrakashYamuna Krishnan
Jun 5, 2021·Materials Science & Engineering. C, Materials for Biological Applications·Yana V TarakanchikovaAlexander S Timin
Oct 16, 2019·Journal of the American Chemical Society·Bo CaiCasey J Krusemark

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.